Healthcare -
Biotechnology - NASDAQ - US
$ 436.28
-10 %
$ 112 B
Market Cap
-214.3
P/E
VRTX - REVENUE
Revenue VRTX - Vertex Pharmaceuticals Incorporated
11 B
LAST VALUE
11.08%
2 YEAR CAGR
21.50%
5 YEAR CAGR
34.23%
10 YEAR CAGR